Raras
Buscar doenças, sintomas, genes...
Acroceratose verruciforme de Hopf
ORPHA:79151CID-10 · Q82.8CID-11 · EC20.YOMIM 101900DOENÇA RARA

Distúrbio genético raro da queratinização da pele com modo de herança autossômico dominante. É caracterizada por numerosas pápulas verrucosas da cor da pele no dorso das mãos, na face medial dos pés, joelhos e cotovelos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distúrbio genético raro da queratinização da pele com modo de herança autossômico dominante. É caracterizada por numerosas pápulas verrucosas da cor da pele no dorso das mãos, na face medial dos pés, joelhos e cotovelos.

Publicações científicas
49 artigos
Último publicado: 2026 Jan

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
+ infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q82.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
7 sintomas
💪
Músculos
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

100%prev.
Hiperceratose
Muito frequente (99-80%)
100%prev.
Acantose epidérmica
Muito frequente (99-80%)
100%prev.
HP:0003577
Frequência: 2/2
90%prev.
Pápula cor da pele
Muito frequente (99-80%)
90%prev.
Distrofia ungueal
Muito frequente (99-80%)
90%prev.
Hipergranulose
Muito frequente (99-80%)
17sintomas
Muito frequente (6)
Frequente (4)
Ocasional (1)
Muito raro (2)
Sem dados (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 17 características clínicas mais associadas, ordenadas por frequência.

HiperceratoseHyperkeratosis
Muito frequente (99-80%)100%
Acantose epidérmicaEpidermal acanthosis
Muito frequente (99-80%)100%
HP:0003577
Frequência: 2/2100%
Pápula cor da peleSkin-colored papule
Muito frequente (99-80%)90%
Distrofia unguealNail dystrophy
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico49PubMed
Últimos 10 anos22publicações
Pico20174 papers
Linha do tempo
2026Hoje · 2026📈 2017Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

ATP2A2Sarcoplasmic/endoplasmic reticulum calcium ATPase 2Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen (PubMed:12542527, PubMed:16402920). Involved in autophagy in response to starvation. Upon interaction with VMP1 and activation, controls ER-isolation membrane contacts for autophagosome formation (PubMed:28890335). Also modulates ER contacts with lipid droplets, mitochondria and endosomes (PubMed:28890335). In coordination with FLVCR2 medi

LOCALIZAÇÃO

Endoplasmic reticulum membraneSarcoplasmic reticulum membrane

VIAS BIOLÓGICAS (3)
Pre-NOTCH Processing in GolgiIon homeostasisIon transport by P-type ATPases
MECANISMO DE DOENÇA

Acrokeratosis verruciformis

A localized disorder of keratinization, which is inherited as an autosomal dominant trait. Its onset is early in life with multiple flat-topped, flesh-colored papules on the hands and feet, punctate keratoses on the palms and soles, with varying degrees of nail involvement. The histopathology shows a distinctive pattern of epidermal features with hyperkeratosis, hypergranulosis and acanthosis together with papillomatosis. These changes are frequently associated with circumscribed elevations of the epidermis that are said to resemble church spires. There are no features of dyskeratosis or acantholysis, the typical findings in lesions of Darier disease.

OUTRAS DOENÇAS (2)
Darier diseaseacrokeratosis verruciformis
HGNC:812UniProt:P16615

Variantes genéticas (ClinVar)

137 variantes patogênicas registradas no ClinVar.

🧬 ATP2A2: NM_170665.4(ATP2A2):c.2788_2790dup (p.Ile930_Trp931insIle) ()
🧬 ATP2A2: NM_170665.4(ATP2A2):c.1389_1390insTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNCCTGACCTCGTGATCCGCCCGCCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGGGAGCCACCGCGCCCGGCCTGAAGGGTCTTTCT (p.Ser463_Lys464insPhePhePhePhePhePheXaaXaaXaaXaaProAspLeuValIleArgProProArgProProLysValLeuGlyLeuGlnAlaGlyAlaThrAlaProGlyLeuLysGlyLeuSer) ()
🧬 ATP2A2: NM_170665.4(ATP2A2):c.1264_1265dup (p.Asp422fs) ()
🧬 ATP2A2: NM_170665.4(ATP2A2):c.2839del (p.Leu947fs) ()
🧬 ATP2A2: NC_000012.12:g.110345247AG[1] ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 27 variantes classificadas pelo ClinVar.

3
4
20
Patogênica (11.1%)
VUS (14.8%)
Benigna (74.1%)
VARIANTES MAIS SIGNIFICATIVAS
ATP2A2: NM_170665.4(ATP2A2):c.2788_2790dup (p.Ile930_Trp931insIle) [Likely pathogenic]
ATP2A2: NM_170665.4(ATP2A2):c.136+21_136+22del [Conflicting classifications of pathogenicity]
ATP2A2: NM_170665.4(ATP2A2):c.2168C>T (p.Thr723Ile) [Uncertain significance]
ATP2A2: NM_170665.4(ATP2A2):c.2030G>C (p.Arg677Pro) [Uncertain significance]
ATP2A2: NM_170665.4(ATP2A2):c.688A>G (p.Thr230Ala) [Uncertain significance]

Vias biológicas (Reactome)

4 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Acroceratose verruciforme de Hopf

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
24 papers (10 anos)
#1

Sporadic Case of Acrokeratosis Verruciformis of Hopf With Unusual Clinical Presentation: A Case Report and Review of the Literature.

Cureus2025 Sep

This study aims to report a sporadic case of acrokeratosis verruciformis of Hopf (or acrokeratosis verruciformis (AKV)) with an unusual clinical presentation, highlighting its diagnostic challenges and key distinguishing features. A 54-year-old female patient with no relevant medical history presented with multiple skin-colored, flat-topped, hyperkeratotic papules on the dorsal aspects of the hands since childhood, and onychopathy for 12 years. Nail changes included thickening of the nail plate and subungual hemorrhages. She presented a soft, warty pink-colored plaque in the right inguinal region. Dermoscopy of the dorsum of the hand showed a white network and papules with a central homogeneous area and a peripheral cobblestone appearance. A biopsy was performed and showed hyperorthokeratosis and epidermal hyperplasia with focal papillomatosis. Treatment was started with keratolytics. The patient has been under follow-up by our department for three months with partial improvement of the lesions.  AKV, a rare genodermatosis, presents a diagnostic challenge due to its subtle onset, relying primarily on clinical presentation and histopathological characteristics. Genetic studies can aid in identifying underlying mutations, with Darier's disease being the main differential diagnosis. Management typically involves keratolytic agents and retinoids, though superficial ablation is considered first-line treatment.  AKV should be suspected in patients presenting with numerous flat, skin-colored, polygonal papules on acral areas and long-standing onychopathy. This case emphasizes the critical role of comprehensive clinical assessment and histopathological study for accurate diagnosis, especially given its unusual manifestations.

#2

"Clinical Overlap of Darier's Disease and Acrokeratosis Verruciformis of Hopf": A Case Report.

Clinical case reports2025 Sep

Darier's disease and Acrokeratosis Verruciformis of Hopf can exhibit overlapping clinical features due to mutations in the same ATP2A2 gene. Recognizing this genetic and phenotypic overlap is crucial for accurate diagnosis, genetic counseling, and treatment, especially in mixed presentations of these rare genodermatoses.

#3

Acrokeratosis verruciformis of Hopf: A rare presentation in a young Indian female-A case report and review.

Journal of family medicine and primary care2025 Mar

Acrokeratosis verruciformis of Hopf (AVH) is a rare dermatological disorder associated with keratotic lesions primarily on the dorsal surfaces of the hands and feet, caused by a missense mutation in the ATP2A2 gene. Here, we report the case of a 24-year-old woman presenting with multiple wart-like lesions on the hands, feet, and neck over four years. A V-shaped notch on the nails indicated nail dystrophy. The patient had no family history of similar symptoms and an unremarkable medical history. The histopathological examination of a skin biopsy revealed marked hyperkeratosis, acanthosis, papillomatosis, and church spire-like epidermal elevations, confirming the diagnosis of AVH. AVH poses diagnostic challenges due to its similarity to other conditions, such as seborrheic keratosis, lichen planus, and Darier disease. Despite resource limitations precluding genetic testing, thorough clinical and histopathological evaluations were crucial for accurate diagnosis. This case underscores the importance of awareness and documentation of AVH, particularly in nonfamilial cases, to facilitate early recognition and management. Increased vigilance among dermatologists is essential to prevent misdiagnosis and to manage this rare condition effectively.

#4

Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene.

JAMA dermatology2024 May 01

Darier disease (DD) is a rare genetic skin disorder caused by heterozygous variants in the ATP2A2 gene. Clinical manifestations include recurrent hyperkeratotic papules and plaques that occur mainly in seborrheic areas. Although some of the lesions wax and wane in response to environmental factors, others are severe and respond poorly to therapy. To investigate the molecular mechanism underlying the persistency of skin lesions in DD. In this case series, DNA was extracted from unaffected skin, transient and persistent lesional skin, and blood from 9 patients with DD. Genetic analysis was used using paired-whole exome sequencing of affected skin and blood or by deep sequencing of ATP2A2 of affected skin. Chromosomal microarray analysis was used to reveal copy number variants and loss of heterozygosity. All variants were validated by Sanger sequencing or restriction fragment length polymorphism. Paired whole-exome sequencing and deep sequencing of ATP2A2 gene from blood and skin samples isolated from persistent, transient lesions and unaffected skin in patients with DD. Germline and somatic genomic characteristics of persistent and transient cutaneous lesions in DD. Of 9 patients with DD, all had heterozygous pathogenic germline variants in the ATP2A2 gene, 6 were female. Participant age ranged from 40 to 69 years on enrollment. All 11 persistent skin lesions were associated with second-hit somatic variants in the ATP2A2 gene. The somatic variants were classified as highly deleterious via combined annotation-dependent depletion (CADD) scores or affect splicing, and 3 of them had been previously described in patients with DD and acrokeratosis verruciformis of Hopf. Second-hit variants in the ATP2A2 gene were not identified in the transient lesions (n = 2) or the normal skin (n = 2). In this study, persistent DD lesions were associated with the presence of second-hit somatic variants in the ATP2A2 gene. Identification of these second-hit variants offers valuable insight into the underlying mechanisms that contribute to the lasting nature of persistent DD lesions.

#5

An Atypical Case of Acrokeratosis Verruciformis of Hopf Responding to Combined Acitretin and Cryotherapy.

Cureus2024 May

Acrokeratosis verruciformis of Hopf (AKVH) is a rare genetic skin condition associated with an ATP2A2 gene mutation, thus affecting keratinization. Classically, AKVH appears in childhood over acral sites as symmetrical, flat, verruca plana-like lesions with an autosomal dominant inheritance, while sporadic cases affect atypical sites in adulthood. As this entity can closely mimic other verrucous skin conditions, identifying characteristic histopathological changes is essential to make a diagnosis in the absence of genetic studies, especially in resource-poor countries. This is the first reported case of AKVH from North-East India clinically mimicking extensive verruca vulgaris in an adult with a possible sporadic occurrence. AKVH is usually difficult to treat and superficial ablation is the treatment of choice. However, this case highlights the role of cryotherapy with acitretin in the management of AKVH with a rapid response.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC39 artigos no totalmostrando 21

2025

Sporadic Case of Acrokeratosis Verruciformis of Hopf With Unusual Clinical Presentation: A Case Report and Review of the Literature.

Cureus
2025

"Clinical Overlap of Darier's Disease and Acrokeratosis Verruciformis of Hopf": A Case Report.

Clinical case reports
2025

Acrokeratosis verruciformis of Hopf: A rare presentation in a young Indian female-A case report and review.

Journal of family medicine and primary care
2024

An Atypical Case of Acrokeratosis Verruciformis of Hopf Responding to Combined Acitretin and Cryotherapy.

Cureus
2024

Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene.

JAMA dermatology
2023

Acrokeratosis Verruciformis of Hopf: A Series of 3 Cases with Clinical, Histopathological and Dermoscopic Features.

Indian journal of dermatology
2022

Acrokeratosis Verruciformis of Hopf in an Adult - A Rare Case Report with Review of Literature.

Indian journal of dermatology
2023

Acrokeratosis verruciformis of Hopf: Dermoscopic approach in lighter phototypes.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

Acrokeratosis verruciformis of Hopf: dermoscopy approach in dark skin patients.

Journal of the European Academy of Dermatology and Venereology : JEADV
2021

Acrokeratosis Verruciformis of Hopf: An Unusual Presentation.

Indian dermatology online journal
2021

Dermoscopy of Acrokeratosis Verruciformis of Hopf.

Indian dermatology online journal
2021

Acrokeratosis verruciformis of Hopf: dermoscopic and histopathological study of two siblings.

Clinical and experimental dermatology
2020

Guttate leukoderma and acrokeratosis verruciformis of Hopf: a rare combination in Darier disease.

Dermatology online journal
2019

Late-onset non-familial acrokeratosis verruciformis of Hopf: a case report.

La Clinica terapeutica
2017

Recurrent ATP2A2 p.(Pro602Leu) mutation differentiates Acrokeratosis verruciformis of Hopf from the allelic condition Darier disease.

American journal of medical genetics. Part A
2017

Brief Report: HPV-17 Infection in Darier Disease With Acrokeratosis Verrucosis of Hopf.

The American Journal of dermatopathology
2017

Mendelian Disorders of Cornification Caused by Defects in Intracellular Calcium Pumps: Mutation Update and Database for Variants in ATP2A2 and ATP2C1 Associated with Darier Disease and Hailey-Hailey Disease.

Human mutation
2016

Acrokeratosis verruciformis of Hopf - Case report.

Anais brasileiros de dermatologia
2016

Acrokeratosis verruciformis of Hopf exhibiting Darier disease-like cytological features.

Clinical and experimental dermatology
2016

Acrokeratosis Verruciformis of Hopf Clinically Mimicking Epidermodysplasia Verruciformis.

Indian journal of dermatology
2015

Nonfamilial acrokeratosis verruciformis of Hopf.

Indian dermatology online journal
Ver todos os 39 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Acroceratose verruciforme de Hopf.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Acroceratose verruciforme de Hopf

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Sporadic Case of Acrokeratosis Verruciformis of Hopf With Unusual Clinical Presentation: A Case Report and Review of the Literature.
    Cureus· 2025· PMID 41054640mais citado
  2. "Clinical Overlap of Darier's Disease and Acrokeratosis Verruciformis of Hopf": A Case Report.
    Clinical case reports· 2025· PMID 40933297mais citado
  3. Acrokeratosis verruciformis of Hopf: A rare presentation in a young Indian female-A case report and review.
    Journal of family medicine and primary care· 2025· PMID 40256087mais citado
  4. Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene.
    JAMA dermatology· 2024· PMID 38536168mais citado
  5. An Atypical Case of Acrokeratosis Verruciformis of Hopf Responding to Combined Acitretin and Cryotherapy.
    Cureus· 2024· PMID 38854358mais citado
  6. Acrokeratosis Verruciformis of Hopf.
    · 2026· PMID 30725935recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79151(Orphanet)
  2. OMIM OMIM:101900(OMIM)
  3. MONDO:0007048(MONDO)
  4. GARD:16707(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q4675784(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Acroceratose verruciforme de Hopf
Compêndio · Raras BR

Acroceratose verruciforme de Hopf

ORPHA:79151 · MONDO:0007048
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
Q82.8 · Outras malformações congênitas especificadas da pele
CID-11
Início
Adult, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0265971
Repurposing
3 candidatos
ingenolPKC activator
retinolretinoid receptor ligand
ureahydroxy radical formation stimulant
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades